Pear Therapeutics IncOver The Counter Market:PEARQ
- LAST PRICE0.0000
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close0.0000 / 0.0000
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Pear Therapeutics Inc | 140.0 | 0.0x | --- |
Todos Medical Ltd | 2.1K | 0.0x | --- |
TRACON Pharmaceuticals Inc | 4.1M | -0.3x | --- |
PhaseBio Pharmaceuticals Inc | 50.0 | 0.0x | --- |
Medicure Inc | 7.6M | -11.3x | --- |
NovaBay Pharmaceuticals Inc | 2.8M | 0.0x | --- |
Company Information
Pear Therapeutics, Inc. is a commercial-stage healthcare company. The Company is engaged in developing a new class of software-based medicines that is referred to as prescription digital therapeutics (PDTs), which use software to treat diseases directly. Its products include reSET and reSET-O. The Company's reSET product is indicated for the treatment of substance use disorder (SUD) as a monotherapy. Its reSET-O product is developed for the treatment of opioid use disorder (OUD) in combination with buprenorphine. The Company’s pipeline consists of product candidates in psychiatry, neurology, and outside-of-central nervous system therapeutic areas. The Company has built a portfolio of PDT product candidates that is primarily focused on psychiatric conditions.
Contact Information
- Headquarters
- 200 State StreetBOSTON, MA, United States 02109
- Phone
- 646-932-2774
- Fax
- 302-636-5454
Executives
- Principal Executive Officer, Chief Financial Officer, Chief Operating Officer, Treasurer, Assistant Secretary
- Christopher Guiffre
- Chief People Officer
- Katherine Jeffery
- Chief Compliance Officer, General Counsel, Secretary
- Ronan O'Brien
- Chief Product Development Officer
- Erin Brenner
- Chief Medical Officer, Head - Development
- Yuri Maricich
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $140.00 |
|---|---|
Revenue (TTM) | $12.7M |
Shares Outstanding | 142.7M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-0.55 |
Book Value | $0.22 |
P/E Ratio | 0.0x |
Price/Sales (TTM) | 0.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -971.72% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
